Hims Preps Peptides, Abbott Syncs with Google, Amazon Targets Pharma
August 12, 2026: Your daily rundown of health and wellness news, in under 5 minutes.
Today's top stories:
Hims CEO Andrew Dudum says the company plans to offer approved peptides by year-end, leveraging 19% subscriber growth to 2.9 million as a distribution channel
Abbott's Lingo glucose data integrates with Google Health's AI Coach, joining Abbott's Whoop investment and Lilly's Oura stake in the race to connect health data
AWS becomes Novo Nordisk's strategic AI partner, launching a joint hub as Amazon's Bio Discovery platform accelerates drug development alongside NVIDIA and OpenAI
Today's…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.